A study in humans demonstrated that the miR-197-5p was significantly downregulated in whole blood of patients with recurrent myocardial infarction after percutaneous coronary intervention compared to those without recurrent events, as identified through next-generation miRNA sequencing and validated with a false discovery rate correction [Onuoha et al. DOI:10.1111/cts.13307].